Cantor Fitzgerald Maintained Ovid Therapeutics Inc. ($OVID) at Overweight rating; Target Price raised to $ 13.00 up from previous mark of $ 7.00
[redirect url=’https://www.cms.stockmarketintellects.com/company-dashboard/?symbol=OVID’ sec=’1′]
Cantor Fitzgerald Maintained Ovid Therapeutics Inc. ($OVID) at Overweight rating; Target Price raised to $ 13.00 up from previous mark of $ 7.00
[redirect url=’https://www.cms.stockmarketintellects.com/company-dashboard/?symbol=OVID’ sec=’1′]
